Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2008-04-08
2008-04-08
Haddad, Maher M. (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S143100, C424S153100
Reexamination Certificate
active
10497991
ABSTRACT:
A novel protein Common Lymphatic Endothelial and Vascular Endothelial Receptor-1 (CLEVER-1) is described. CLEVER-1 mediates leukocyte and malignant cell binding to vascular and lymphoid endothelial cells. CLEVER-1 is the first protein that has been reported to mediate both influx into and efflux from the lymph nodes. Also provided are methods of treating inflammation and preventing metastasis of malignant cells by providing an inhibitor of CLEVER-1 binding.
REFERENCES:
patent: 5484596 (1996-01-01), Hanna et al.
patent: 5840844 (1998-11-01), Lasky et al.
patent: 6166179 (2000-12-01), Rice et al.
patent: 6713059 (2004-03-01), Kende et al.
patent: 2003/0108984 (2003-06-01), Naor et al.
patent: WO 00/39166 (2000-07-01), None
Salmi et al CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood. Dec. 15, 2004;104(13):3849-57.
Norman and Kubes Therapeutic intervention in inflammatory diseases: a time and place for anti-adhesion therapy. Microcirculation. Jan-Feb. 2005;12(1):91-8.
Kzhyshkowska et al. Stabilin-1, a homeostatic scavenger receptor with multiple functions. J Cell Mol Med. Jul.-Sep. 2006;10(3):635-49.
Prevo et al. Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (FEEL-1/CLEVER-1). J Biol Chem. Dec. 10, 2004;279(50):52580-92.
Lerner RA, Tapping the immunological repertoire to produce antibodies of predetermined specificity. Nature 1982; 299:593-596, see p. 595-596.
Adachi, H. and Tsujimoto, M., “FEEL-1, a Novel Scavenger Receptor with in Vitro Bacteria-binding and Angiogenesis-modulating Activities,”J. Biol. Chem. 277:34264-34270, The American Society for Biochemistry and Molecular Biology, Inc. (Sep. 2002).
Database EM-HUM Online, Accession No. HSD433, retrieved from EBI (created 1996, as updated Jul. 5, 2002).
Sequence comparison between Database EM-HUM Online, Accession No. HSD433, retrieved from EBI (Document No. AT1) (created 1996, as updated Jul. 5, 2002) with SEQ ID No. 1.
Database SWALL Online, Accession No. Q93072, retrieved from EBI (created 1997, as updated Jun. 1, 2003).
Sequence comparison between Database SWALL Online, Accession No. Q93072, retrieved from EBI (Document No. AS2) (created 1997, as updated Jun. 1, 2003) with the protein sequence of SEQ ID No. 1.
Nagase, T., et al., “Prediction of the Coding Sequences of Unidentified Human Genes. VI. The Coding Sequences of 80 New Genes (KIAA0201-KIAA0280) Deduced by Analysis of cDNA Clones from Cell Line KG-1 and Brain,”DNA Res. 3:321-329, Kazusa DNA Research Institute and Universal Academy Press (1996).
Database EM-HUM Online, Accession No. HSA275213, retrieved from EBI (created 1999, as updated Feb. 14, 2003).
Sequence comparison between Database EM-HUM Online, Accession No. HSA275213, retrieved from EBI (Document No. AS3) (created 1999, as updated Feb. 14, 2003) with SEQ. ID. No. 1.
Database SWALL Online, Accession No. Q9NY15, retrieved from EBI (created 2000, as updated Jun. 1, 2003).
Sequence comparison between Database SWALL Online, Accession No. Q9NY15, retrieved from EBI (Document No. AR4) (created 2000, as updated Jun. 1, 2003) with the protein sequence of SEQ. ID. No. 1.
Database GSN Online, Accession No. AAA57362, retrieved from EBI (2000).
Sequence comparison between Database GSN Online, Accession No. AAA57362, retrieved from EBI (Document No. AT4) (2000) with SEQ. ID. No. 1 lacking nucleotides 2914-3009.
Sequence comparison between Database GSN Online, Accession No. AAA57362, retrieved from EBI (Document No. AT4) (2000) with SEQ. ID. No. 1.
Database GSP Online, Accession No. AAY93910, retrieved from EBI (2000).
Sequence comparison between Database GSP Online, Accession No. AAY93910, retrieved from EBI (Document No. AT5) (2000) with SEQ. ID. No. 1 lacking nucleotides 2914-3009.
Sequence comparison between Database GSP Online, Accession No. AAY93910, retrieved from EBI (Document No. AT5) (2000) with SEQ. ID. No. 1.
Johnansson, I.H., et al, “Mechanisms of lymphocyte exit from lymphoid tissues,”Immunol. Lett., Abstracts of the 14thEuropean Immunology Meeting EFIS 2000, Abstract No. 391, pp. 170, Elsevier/North Holland Biomedical Press (2000).
Database SWALL Online, Accession No. Q93073, retrieved from EBI (created 1997, as updated Jul. 5, 2004).
Irjala Heikki
Jalkanen Sirpa
Salmi Marko
Faron Pharmaceuticals Oy
Haddad Maher M.
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Common lymphatic endothelial and vascular endothelial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Common lymphatic endothelial and vascular endothelial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Common lymphatic endothelial and vascular endothelial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3925885